Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide
5-hydroxythalidomide is a primary thalidomide metabolite generated by the cytochrome P450 isozymes. The reported data, including crystal structure of the 5-hydroxythalidomide-mediated complex of CRBN with SALL4, elucidate how additional hydroxy group of the metabolite enhances the interaction of CRB...
Guardado en:
Autores principales: | Hirotake Furihata, Satoshi Yamanaka, Toshiaki Honda, Yumiko Miyauchi, Atsuko Asano, Norio Shibata, Masaru Tanokura, Tatsuya Sawasaki, Takuya Miyakawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e6839866ce1b4a9fbf178c9bea0007d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Agentes inmunomoduladores (IMiDs): herramientas para el tratamiento del mieloma múltiple
por: Fernández-Lázaro,Diego, et al.
Publicado: (2018) -
pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4CRBN ubiquitin ligase
por: Jian An, et al.
Publicado: (2017) -
NMR-based metabolomics for simultaneously evaluating multiple determinants of primary beef quality in Japanese Black cattle
por: Yoshinori Kodani, et al.
Publicado: (2017) -
Gdzie walczył i jak miał na imię brat Mieszka I?
por: Michał Łuczyński
Publicado: (2020) -
A hospital-wide outbreak of IMI-17-producing Enterobacter ludwigii in an Israeli hospital
por: Vered Schechner, et al.
Publicado: (2021)